Accessibility settings

Published on in Vol 15 (2026)

This is a member publication of

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/105338, first published .
Nurse preparing blood collection tubes for patient, with medical supplies on table.

Epigenetic Profiling for Early Detection and Treatment Response Monitoring in Non–Small Cell Lung Cancer: Protocol for a Prospective Translational Biomarker Study

Epigenetic Profiling for Early Detection and Treatment Response Monitoring in Non–Small Cell Lung Cancer: Protocol for a Prospective Translational Biomarker Study

Rajiv Kumar   1, 2, 3 , BMedSci, MBChB, MD(Res) ;   Safia May Farry   1 , BBiomedSc(Hons) ;   Mark Ezegbogu   1 , MSc ;   Glen Reid   1 , PhD ;   Euan James Rodger   1 , PhD ;   Ben Brockway   2, 4 * , MBBS ;   Aniruddha Chatterjee   1 * , PhD

1 Department of Pathology and Molecular Medicine, Faculty of Medicine - Dunedin, University of Otago, Dunedin, New Zealand

2 Department of Medicine, Faculty of Medicine - Dunedin, University of Otago, Dunedin, New Zealand

3 Mercy Cancer Care, Mercy Hospital, Dunedin, New Zealand

4 Te Whatu Ora – Southern, Health New Zealand, Dunedin, New Zealand

*these authors contributed equally

Corresponding Author:

  • Aniruddha Chatterjee, PhD
  • Department of Pathology and Molecular Medicine, Faculty of Medicine - Dunedin
  • University of Otago
  • 58 Hanover Street, Hercus Building
  • Dunedin 9016
  • New Zealand
  • Phone: 64 210701558
  • Email: aniruddha.chatterjee@otago.ac.nz